Gentry George Teng King, MD

Fred Hutchinson Cancer Center, University of Washington

Associate professor of medical oncology

Published Articles (1)

Precision Frontiers in Hepatobiliary Oncology: Evaluating FGFR2 Selectivity and the Evolving Role of Immunotherapy

March 24, 2026

Expert analysis of FGFR2-targeted therapy in intrahepatic cholangiocarcinoma and the evolving role of immunotherapy in hepatocellular carcinoma, from adjuvant setbacks to perioperative and first-line advances.